PharOS Ltd
Pandora V. Alexaki is an experienced professional in product development and formulation science, currently serving as a Product Development Manager at PharOS Ltd since November 2010, with prior roles including Senior Supervisor and Supervisor. Responsibilities include overseeing formulation and analytical development activities within a research and development lab, as well as providing scientific consulting during drug development and regulatory submission processes. Earlier experience at Genepharm S.A. involved coordinating generic formulation development projects and supervising scale-up and registration batches. Pandora's career began at EVGA S.A. as a Quality Control Assistant. Academic qualifications include an MSc in Food Science and Technology from the Agricultural University of Athens and a BSc in Chemistry from the University of Crete.
This person is not in any offices
PharOS Ltd
Developing Value, Supplying Success PharOS is a privately owned company located in Greece and is considered among the fastest growing Pharmaceutical Development companies in Europe. PharOS is providing a diversified range of own & co-developed pharmaceutical products, including Generics, OTCs & FDCs. In parallel, PharOS is providing value added services in the field of Product Development, Regulatory Affairs and Business Development Consulting, PharOS Polska was founded in 2008, through a joint venture of PharOS Ltd. and the Swiss-based company Nortrade Pharma. Through its local presence, the company will increase its focus and market presence in the rapidly emerging Central and Eastern Europe. In 2018 PharOS acquired the Hal-far ex-Arrow Pharma manufacturing plant in in Malta. Proud founding member of EuDRAcon (https://eudracon.eu)